Fijians are currently grappling with significant medicine shortages, causing delays for patients seeking essential treatments. The Pharmaceutical and Biomedical Services (FPBS), responsible for supplying over 200 health facilities across the country, has pointed to a mix of external and internal challenges that are causing these disruptions.
These facilities include three divisional hospitals, 12 specialist hospitals, 21 sub-divisional hospitals, 94 health centres, and 47 nursing stations. According to FPBS Director Jeremaia Mataika, some suppliers have been unable to deliver quality medicines in line with their contractual obligations, leading to returns of substandard products and further delays. “Sometimes, we find out medicines are of no good quality after procurement, and we have to send them back,” Mr. Mataika explained. The situation is particularly concerning for non-communicable diseases (NCDs), creating a ripple effect during times of increased demand.
The crisis is further compounded by bureaucratic delays in procurement approvals, especially from the Solicitor-General’s Office. These internal challenges, alongside supplier issues, have led to significant gaps in essential medicine stocks. Health Minister Dr. Ratu Atonio Lalabalavu confirmed that contracts with non-compliant suppliers have been terminated and emphasized the search for alternatives to fill these gaps.
The shortages raise alarming health risks, particularly for patients managing chronic conditions who rely on timely access to effective medications. Public health experts are advocating for a comprehensive reform of Fiji’s medicine procurement system to enhance transparency, accountability, and efficiency. Critics argue that existing frameworks, bound by the Financial Management Act 2004 and Procurement Regulation 2010, are too rigid to address urgent public health needs.
As stakeholders call for change, the Ministry of Health and Medical Services recognizes the necessity for reform. However, until systemic improvements are enacted, vulnerable populations may continue to face challenges in accessing the medicines they require.
This situation underscores the urgent need for a more responsive healthcare system that prioritizes patient needs. With proactive steps towards reform, there is hope that future medicine procurement processes will ensure every Fijian has access to safe and effective medications when they need them the most.
Leave a comment